Evaluation of 99mTcN-15C5 as a new myocardial perfusion imaging agent in normal dogs and canines with coronary stenosis

Nuclear Medicine Communications

Volumn 29, Issue 9, 2008, Pages 775-781

  Fang, Wei ^a   Liu, Yajing ^a   Zhu, Lin ^a   Kim, Young Seung ^a   Liu, Shuang ^a   He, Zuo Xiang ^a  

^a PURDUE UNIVERSITY   (United States)

Author keywords

Biodistribution; Coronary stenoses; Liver clearance; Myocardial perfusion imaging

Indexed keywords

[N (DITHIOCARBAMATO) 2 AMINIMETHYL 15 CROWN 5][N,N BIS[2 [BIS(3 ETHOXYPROPYL)PHOSPHINO]ETHYL]METHOXYETHYLAMINE]NITRIDOTECHNETIUM TC 99M; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; TECHNETIUM 99M; UNCLASSIFIED DRUG; ADENOSINE; DIAGNOSTIC AGENT; RADIOPHARMACEUTICAL AGENT; TECHNETIUM 99M (N (DITHIOCARBAMATO) 2 AMINOMETHYL 15 CROWN 5)(N,N BIS(2 (3 ETHOXYPROPYL)PHOSPHINO)ETHYL)METHOXYETHYLAMINE; TECHNETIUM 99M (N-(DITHIOCARBAMATO)-2-AMINOMETHYL-15-CROWN-5)(N,N-BIS(2-(3-ETHOXYPROPYL)PHOSPHINO)ETHYL)METHOXYETHYLAMINE; TECHNETIUM COMPLEX;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY OBSTRUCTION; DOG; DRUG CLEARANCE; DRUG STRUCTURE; DRUG SYNTHESIS; HEART; HEART MUSCLE PERFUSION; LIVER; LIVER CLEARANCE; LUNG; NONHUMAN; RADIOISOTOPE DISTRIBUTION; SCINTIANGIOCARDIOGRAPHY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TISSUE DISTRIBUTION; ANIMAL; ANIMAL DISEASE; CHEMICAL MODEL; HEART MUSCLE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; KINETICS; METHODOLOGY; PATHOLOGY; PERFUSION; SCINTISCANNING;

ADENOSINE; ANIMALS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CORONARY STENOSIS; DOGS; HEART; KINETICS; LUNG; MODELS, CHEMICAL; MYOCARDIUM; ORGANOTECHNETIUM COMPOUNDS; PERFUSION; RADIOPHARMACEUTICALS; TECHNETIUM TC 99M SESTAMIBI; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 53149130621     PISSN: 01433636     EISSN: 14735628     Source Type: Journal    
DOI: 10.1097/MNM.0b013e328302ca4a     Document Type: Article

References (27)

1. Nunn AD. Radiopharmaceuticals for imaging myocardial perfusion. Semin Nucl Med 1990; 20:111-118.
2. Saha GB, Go RT, Macintyre WJ. Radiopharmaceuticals for cardiovascular imaging. Nucl Med Biol 1992; 19:1-20.
3. Opie LH, Hesse B. Radionuclide tracers in the evaluation of resting myocardial ischemia and viability. Eur J Nucl Med 1997; 24:1183-1193.
4. Berman DS, Germano G, Shaw LJ. The role of nuclear cardiology in clinical decision making. Semin Nucl Med 1999; 29:280-297.
5. Jain D. Technetium-99m labeled myocardial perfusion imaging agents. Semin Nucl Med 1999; 29:221-236.
6. Acampa W, Di Benedetto C, Cuocolo A. An overview of radiotracers in nuclear cardiology. J Nucl Cardiol 2000; 7:701-707.
7. Dilsizian V. The role of myocardial perfusion imaging in vascular endothelial dysfunction. J Nucl Cardiol 2000; 7:180-184.
8. Beller GA, Zaret BL. Contributions of nuclear cardiology to diagnosis and prognosis of patients with coronary artery disease. Circulation 2000; 101:1465-1478.
9. Russell RR III, Zaret BL. Nuclear cardiology: present and future. Curr Probl Cardiol 2006; 31:557-629.
10. Llaurado JG. The quest for the perfect myocardial perfusion indicator … still a long way to go. J Nucl Med 2001; 42:282-284.
11. Banerjee S, Pillai MRA, Ramamoorthy N. Evolution of Tc-99m in diagnostic radiopharmaceuticals. Semin Nucl Med 2001; 31:260-277.
12. Parker JA. Cardiac nuclear medicine in monitoring patients with coronary heart disease. Semin Nucl Med 2001; 31:223-237.
13. Kapur A, Latus KA, Davies G, Dhawan RT, Eastick S, Jarritt PH, et al. A comparison of three radionuclide myocardial perfusion tracers in clinical practice: the ROBUST study. Eur J Nucl Med 2002; 29:1608-1616.
14. Kailasnath P, Sinusus AJ. Comparison of Tl-201 with Tc-99m-labeled myocardial perfusion agents: technical, physiological, and clinic issues. J Nucl Cardiol 2001; 8:482-498.
15. Samady H, Wackers FJ, Joska TM, Zaret BL, Jain D. Pharmacologic stress perfusion imaging with adenosine: role of simultaneous low-level treadmill exercise. J Nucl Cardiol 2002; 9:188-196.
16. 2en=N, N′-ethylenebis[acetylacetone iminato]). Nucl Med Biol 1999; 26:755-770.
17. + complexes containing ether analogs of DMPE. Nucl Med Biol 1999; 26:563-571.
18. + complexes as potential myocardial perfusion imaging agents (DIARS=o-phenylenebis(dimethylarsine); SR=thiolate). J Med Chem 1996; 39:1253-1261.
19. + for cardiac imaging. J Nucl Med 2004; 45:215P (abstract No. 703).
20. 99mTc heterocomplexes as heart imaging agents with improved biological properties. Nucl Med Commun 2002; 23:689-693.
21. 99mTc-nitrido complexes as new radiopharmaceuticals for heart imaging. Nucl Med Biol 2006; 33:419-432.
22. 99mTc radiotracers. Inorg Chim Acta 2006; 359:2479-2488.
23. 99mTc (I)-tricarbonyl complexes as potential radiotracers for myocardial perfusion imaging. Nucl Med Biol 2006; 33:1045-1053.
24. 99mTc complexes useful as radiopharmaceuticals for heart imaging. Dalton Trans 2007; 12:1183-1193.
25. 99mTc-nitrido complexes. Bioconj Chem 2007; 18:929-936.
26. 99mTc-tetrofosmin in rats. J Nucl Med 2004; 45:2095-2101.
27. Hatada K, Ruiz M, Riou LM, Lima RL, Goode AR, Watson DD, et al. Organ distribution and myocardial uptake, washout, and redistribution kinetics of Tc-99m N-DBODC5 when injected during vasodilator stress in canine models of coronary stenoses. J Nucl Cardiol 2006; 13:779-790.